| Literature DB >> 9593167 |
C Shirai1, M Sugai, H Komatsuzawa, K Ohta, M Yamakido, H Suginaka.
Abstract
Cibacron blue F3GA (CB) was found to reduce the MIC of oxacillin for methicillin-resistant Staphylococcus aureus (MRSA). This effect was not observed with methicillin-susceptible S. aureus. CB alters the resistance level of MRSA through a factor(s) other than mecA-related products, major autolysins, or femAB products. The exact target(s) of CB in causing the effect is unknown.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9593167 PMCID: PMC105803 DOI: 10.1128/AAC.42.5.1278
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191